<?xml version="1.0" encoding="UTF-8"?>
<results title="plant_compound">
 <result pre="such as: Î±-pinene, Î²-pinene, carvacrol, eugenol, limonene, myrcene, ocimene, cineole," exact="methyl salicylate," post="farnesene, and thymol. The goal of this study was"/>
 <result pre="used. All the evaluated compounds presented antimicrobial activity. The compounds" exact="eugenol" post="and carvacrol showed the largest inhibition zones. Regarding yeasts,"/>
 <result pre="the evaluated compounds presented antimicrobial activity. The compounds eugenol and" exact="carvacrol" post="showed the largest inhibition zones. Regarding yeasts, the compounds"/>
 <result pre="did not show any activity. The compounds eugenol, carvacrol, and" exact="thymol" post="presented the lowest MIC; bactericidal effect was observed at"/>
 <result pre="are recently reported. For example, it has been observed that" exact="clove oil," post="for which main component is eugenol, has antibacterial activity"/>
 <result pre="among them: Î±-pinene, Î²-pinene, carvacrol, eugenol, limonene, myrcene, ocimene, cineole," exact="methyl salicylate," post="farnesene, and thymol. Some studies have been carried out"/>
 <result pre="carried out on these compounds, among which we can mention" exact="thymol" post="[14,15], carvacrol [16,17], Î±-pinene [18], and eugenol [19,20,21] and"/>
 <result pre="on these compounds, among which we can mention thymol [14,15]," exact="carvacrol" post="[16,17], Î±-pinene [18], and eugenol [19,20,21] and it was"/>
 <result pre="we can mention thymol [14,15], carvacrol [16,17], Î±-pinene [18], and" exact="eugenol" post="[19,20,21] and it was observed that they present antimicrobial"/>
 <result pre="that include Î±-pinene, Î²-pinene, carvacrol, eugenol, limonene, myrcene, ocimene, cineole," exact="methyl salicylate," post="farnesene, and thymol. 2. Results 2.1. Qualitative Evaluation of"/>
 <result pre="the highest inhibition zones for Gram-positive and Gram-negative bacteria were" exact="carvacrol" post="and eugenol; Î±-pinene, Î²-pinene, and myrcene were the compounds"/>
 <result pre="and Gram-negative bacteria were carvacrol and eugenol; Î±-pinene, Î²-pinene, and" exact="myrcene" post="were the compounds that presented the lowest inhibition zones"/>
 <result pre="in Table 4, Table 5 and Table 6. The compounds" exact="carvacrol" post="and eugenol presented the smallest minimum inhibitory concentrations for"/>
 <result pre="4, Table 5 and Table 6. The compounds carvacrol and" exact="eugenol" post="presented the smallest minimum inhibitory concentrations for the bacterial"/>
 <result pre="values for both bacterial types. The compounds carvacrol, eugenol, and" exact="thymol" post="presented the lowest MICs in yeast (Table 6), and"/>
 <result pre="presented concentrations greater than or equal to 2 mg/mL. The" exact="eugenol" post="(0.125â€&quot;0.250 mg/mL), carvacrol (0.03 mg/mL), and thymol (0.03â€&quot;0.250 mg/mL)"/>
 <result pre="than or equal to 2 mg/mL. The eugenol (0.125â€&quot;0.250 mg/mL)," exact="carvacrol" post="(0.03 mg/mL), and thymol (0.03â€&quot;0.250 mg/mL) compounds were those"/>
 <result pre="2 mg/mL. The eugenol (0.125â€&quot;0.250 mg/mL), carvacrol (0.03 mg/mL), and" exact="thymol" post="(0.03â€&quot;0.250 mg/mL) compounds were those that presented the lowest"/>
 <result pre="tested compounds showed activity in multi-resistant strains (eugenol, limonene, carvacrol," exact="methyl salicylate," post="farmesene, and thymol). 2.3. Time-Killing Curves Once the MIC,"/>
 <result pre="MR) and a yeast (C albicans CUSI), for the compounds" exact="eugenol" post="(Figure 1aâ€&quot;c), carvacrol (Figure 2aâ€&quot;c), and thymol (Figure 3aâ€&quot;c)"/>
 <result pre="yeast (C albicans CUSI), for the compounds eugenol (Figure 1aâ€&quot;c)," exact="carvacrol" post="(Figure 2aâ€&quot;c), and thymol (Figure 3aâ€&quot;c) were evaluated (the"/>
 <result pre="for the compounds eugenol (Figure 1aâ€&quot;c), carvacrol (Figure 2aâ€&quot;c), and" exact="thymol" post="(Figure 3aâ€&quot;c) were evaluated (the strains were chosen for"/>
 <result pre="the compounds for presenting the lowest MIC values). For the" exact="eugenol" post="compound in the bacterial population of S. aureus 75MR,"/>
 <result pre="C. albicans CUSI, at 4 h (Figure 2aâ€&quot;c). The compound" exact="thymol" post="completely inhibited bacterial growth at the first hour of"/>
 <result pre="at 2 h (Figure 3aâ€&quot;c). As shown in the figures," exact="carvacrol" post="and thymol compounds presented a bactericidal or fungicidal behavior"/>
 <result pre="h (Figure 3aâ€&quot;c). As shown in the figures, carvacrol and" exact="thymol" post="compounds presented a bactericidal or fungicidal behavior on the"/>
 <result pre="carvacrol, presenting the lowest MIC values (0.03â€&quot;0.06 mg/mL), followed by" exact="carvacrol" post="(0.03â€&quot;0.25 mg/mL), and finally eugenol (0.125â€&quot;0.25 mg/mL). 3. Discussion"/>
 <result pre="values (0.03â€&quot;0.06 mg/mL), followed by carvacrol (0.03â€&quot;0.25 mg/mL), and finally" exact="eugenol" post="(0.125â€&quot;0.25 mg/mL). 3. Discussion The results show that the"/>
 <result pre="membranes, increasing membrane permeability [4,22,23,24,25]. The compounds eugenol, carvacrol, and" exact="thymol" post="showed the highest antimicrobial activity against Gran positive bacteria,"/>
 <result pre="present activity on yeast (myrcene) and the other not (ocimeno);" exact="carvacrol" post="and thymol differ in the position of a hydroxyl"/>
 <result pre="on yeast (myrcene) and the other not (ocimeno); carvacrol and" exact="thymol" post="differ in the position of a hydroxyl group (in"/>
 <result pre="thymol differ in the position of a hydroxyl group (in" exact="thymol" post="is in ortho position, in carvacrol it is in"/>
 <result pre="a hydroxyl group (in thymol is in ortho position, in" exact="carvacrol" post="it is in meta position), causing the deterioration of"/>
 <result pre="the destruction or inactivity of genetic material [17,29,30]. Thymol and" exact="carvacrol" post="are lipophilic and can enter between the fatty acid"/>
 <result pre="cell membranes; in the case of yeast, compounds such as" exact="carvacrol" post="can affect the regulation and the functioning of membrane"/>
 <result pre="carvacrol, presenting the lowest MIC values (0.03â€&quot;0.125 mg/mL), followed by" exact="eugenol" post="(0.25â€&quot;0.75 mg/mL), and lastly thymol (0.25â€&quot;1.0 mg/mL). Gram-negative bacterial"/>
 <result pre="values (0.03â€&quot;0.125 mg/mL), followed by eugenol (0.25â€&quot;0.75 mg/mL), and lastly" exact="thymol" post="(0.25â€&quot;1.0 mg/mL). Gram-negative bacterial strains were also more sensitive"/>
 <result pre="carvacrol, presenting the lowest MIC values (0.06â€&quot;0.25 mg/mL), followed by" exact="eugenol" post="(0.06â€&quot;0.5 mg/mL), and lastly thymol (0.25â€&quot;0.5 mg/mL). In regards"/>
 <result pre="values (0.06â€&quot;0.25 mg/mL), followed by eugenol (0.06â€&quot;0.5 mg/mL), and lastly" exact="thymol" post="(0.25â€&quot;0.5 mg/mL). In regards to time-killing curves, it was"/>
 <result pre="S. aureus 75MR after 1 h of contact. Carvacrol and" exact="thymol" post="showed a bactericidal and fungicidal effect at MIC level."/>
 <result pre="studied in detail [32]. Components of essential oils such as" exact="thymol" post="and carvacrol have previously been reported to have properties"/>
 <result pre="detail [32]. Components of essential oils such as thymol and" exact="carvacrol" post="have previously been reported to have properties that cause"/>
 <result pre="typhimurium [12,33]. On the other hand, it was shown that" exact="eugenol" post="can disintegrate in the membrane and increase its permeability,"/>
 <result pre="Î±-pinene 98% (# cat. 147524), Î²-pinene 99% (# cat. 112089)," exact="carvacrol" post="98% (# cat. 282197), eugenol 99% (# cat. E51791),"/>
 <result pre="Î²-pinene 99% (# cat. 112089), carvacrol 98% (# cat. 282197)," exact="eugenol" post="99% (# cat. E51791), limonene 97% (# cat. 183164),"/>
 <result pre="eugenol 99% (# cat. E51791), limonene 97% (# cat. 183164)," exact="myrcene" post="90% (# cat. M100005), ocimene 90% (cat. # W353901-1006),"/>
 <result pre="ocimene 90% (cat. # W353901-1006), cineole 99% (cat. # C80601)," exact="methyl salicylate" post="98% (cat. # W274518), farnesene 90% (cat. # W383902),"/>
 <result pre="98% (cat. # W274518), farnesene 90% (cat. # W383902), and" exact="thymol" post="98.5% (cat. # T0501) were obtained from Sigma-Aldrich (Toluca,"/>
 <result pre="ÂµL of each compound (Î±-pinene 3.4 mg, Î²-pinene 3.4 mg," exact="carvacrol" post="3.9 mg, eugenol 4.3 mg, limonene 3.4 mg, myrcene"/>
 <result pre="compound (Î±-pinene 3.4 mg, Î²-pinene 3.4 mg, carvacrol 3.9 mg," exact="eugenol" post="4.3 mg, limonene 3.4 mg, myrcene 3.2 mg, ocimene"/>
 <result pre="mg, carvacrol 3.9 mg, eugenol 4.3 mg, limonene 3.4 mg," exact="myrcene" post="3.2 mg, ocimene 3.3 mg, cineole 3.7 mg, methyl"/>
 <result pre="mg, myrcene 3.2 mg, ocimene 3.3 mg, cineole 3.7 mg," exact="methyl salicylate" post="4.7 mg, farnesene 3.4 mg) and placed on the"/>
 <result pre="different bacterial groups and yeasts. The compounds carvacrol, eugenol, and" exact="thymol" post="were those that showed the highest antimicrobial activity. Carvacrol"/>
 <result pre="was the component with the highest antibacterial activity, followed by" exact="eugenol" post="and thymol. Carvacrol was the component with the highest"/>
 <result pre="was the component with the highest antifungal activity, followed by" exact="thymol" post="and lastly eugenol. The compounds ocimene, cineole, and farnesene"/>
 <result pre="envelope of Candida albicansFitoterapia20077839640010.1016/j.fitote.2007.02.02217590533 15.KachurK.SuntresZ.The antibacterial properties of phenolic isomers," exact="carvacrol" post="and thymolCrit. Rev. Food Sci. Nutr.2020603042305310.1080/10408398.2019.167558531617738 16.GuardaA.RubilarJ.F.MiltzJ.GalottoM.J.The antimicrobial activity"/>
 <result pre="thymolCrit. Rev. Food Sci. Nutr.2020603042305310.1080/10408398.2019.167558531617738 16.GuardaA.RubilarJ.F.MiltzJ.GalottoM.J.The antimicrobial activity of microencapsulated" exact="thymol" post="and carvacrolInt. J. Food Microbiol.201114614415010.1016/j.ijfoodmicro.2011.02.01121411168 17.SilvaE.R.De CarvalhoF.O.TeixeiraL.G.B.SantosN.G.L.FelipeF.A.SantanaH.S.R.ShanmugamS.JÃºniorL.J.Q.AraujoA.A.d.S.NunesP.S.Pharmacological Effects of"/>
 <result pre="vitro and in silico inhibitory effects of synthetic and natural" exact="eugenol" post="derivatives against the NorA efflux pump in Staphylococcus aureusFood"/>
 <result pre="inhibitory concentration and mode of action of oregano essential oil," exact="thymol" post="and carvacrolJ. Appl. Microbiol.20019145346210.1046/j.1365-2672.2001.01428.x11556910 33.JirovetzL.BuchbauerG.StoilovaI.StoyanovaA.KrastanovA.SchmidtE.Chemical composition and antioxidant properties"/>
</results>
